BlueCrest Capital Management
AXNX icon

BlueCrest Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

BlueCrest Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,400
Closed -$404K – 355
2023
Q1 		$404K Buy
+7,400
New +$432K 0.01% 197

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Hood River Capital Management
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

BlueCrest Capital Management's AXNX Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 7,400 shares — an estimated $404K sold.

BlueCrest Capital Management first reported a position in AXNX in Q1 2023 and held it in 1 quarter. The position peaked at $404K in Q1 2023. 234 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 7,400 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $404K.
  • BlueCrest Capital Management first reported a position in Axonics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • BlueCrest Capital Management's Axonics, Inc. Common Stock position peaked at $404K in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.